- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Breast Cancer Female in United States
Total 28525 results
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLCCompletedMale Breast Cancer | Breast - FemaleUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNovartisCompletedBreast Cancer | Breast Cancer - Female | Breast Cancer - MaleUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteHorizon Pharma Ireland, Ltd., Dublin IrelandCompletedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer FemaleUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseActive, not recruitingBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | Invasive Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | HER2 Positive Breast Carcinoma | Stage III Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteTerminatedBreast Cancer | Breast Cancer, Male | HER2-positive Breast Cancer | HER-2 Gene Amplification | Breast Cancer Female | HER2 Positive Breast Carcinoma | HER-2 Protein OverexpressionUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteWithdrawnBreast Cancer | Breast Neoplasms | Breast Cancer, Male | Breast Cancer, FemaleUnited States
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
Wake Forest University Health SciencesAtrium Health NavicentActive, not recruitingBreast Cancer Female | Early-stage Breast CancerUnited States
-
University of Illinois at ChicagoRecruitingBreast Cancer Female | Breast Cancer InvasiveUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteUnited States Department of DefenseActive, not recruitingBreast Cancer, Male | HER2-positive Breast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Residual Disease | HER2 Positive Breast CarcinomaUnited States
-
Mayo ClinicRecruitingBreast Cancer | Breast Carcinoma | Breast Cancer FemaleUnited States
-
Dana-Farber Cancer InstituteBreast Cancer Research FoundationNot yet recruitingBreast Cancer | Breast Cancer FemaleUnited States
-
Colin Champ, MDRecruitingBreast Cancer FemaleUnited States
-
Sentara Norfolk General HospitalActive, not recruiting
-
Fox Chase Cancer CenterAmerican Cancer Society, Inc.CompletedBreast Cancer FemaleUnited States
-
University of Wisconsin, MadisonAmgenCompleted
-
University of PittsburghWithdrawnBreast Cancer FemaleUnited States
-
Dana-Farber Cancer InstituteNot yet recruitingBreast Cancer | Breast Carcinoma | Breast Cancer FemaleUnited States
-
Georgetown UniversityKaiser PermanenteCompletedBreast Cancer Female | Breast DensityUnited States
-
University of Colorado, DenverWithdrawnFertility Changes Due to Cancer: an Investigation of Meaning, Psychological Distress, and PsychologiBreast Cancer FemaleUnited States
-
Massachusetts General HospitalPfizer; American Cancer Society, Inc.RecruitingBreast Cancer | Breast Neoplasms | Breast Carcinoma | Breast Cancer FemaleUnited States
-
University of Illinois at ChicagoRecruiting
-
University of Alabama at BirminghamCompletedFemale Breast CancerUnited States
-
Tarah J Ballinger, MDCompletedBreast Cancer | Breast Cancer FemaleUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteSaladax Biomedical, Inc.CompletedBreast Cancer | Breast Cancer FemaleUnited States
-
Texas Tech University Health Sciences CenterTexas Tech UniversityCompletedBreast Cancer FemaleUnited States
-
University of Michigan Rogel Cancer CenterNational Cancer Institute (NCI)CompletedBreast Cancer Female | Survivorship | Early-stage Breast Cancer | Cancer Survivors | Transitional CareUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Terminated
-
Stony Brook UniversityWithdrawnBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | DCISUnited States
-
Immunis.AIDuke UniversityNot yet recruitingBreast Cancer | Breast Cancer FemaleUnited States
-
University of Michigan Rogel Cancer CenterNot yet recruitingBreast Cancer FemaleUnited States
-
Shayna Showalter, MDActive, not recruitingBreast Cancer FemaleUnited States
-
University of ArizonaNational Cancer Institute (NCI)RecruitingPsychological Distress | Breast Cancer FemaleUnited States
-
Johns Hopkins UniversityCompletedBreast Cancer Female | Adriamycin ToxicityUnited States
-
Wendie BergBreast Cancer Research FoundationActive, not recruitingNeoplasms | Breast Cancer | Breast Neoplasms | Breast Cancer FemaleUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Breast Cancer FemaleUnited States, Nigeria
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); University of Pittsburgh; Case Western Reserve...RecruitingBreast Cancer | Stage I Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | Stage III Breast CancerUnited States
-
Georgetown UniversityUnknownBreast Cancer FemaleUnited States
-
Baylor Breast Care CenterRecruitingBreast Cancer | Breast Neoplasm | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | HER2-positive Breast Cancer | Breast Cancer Stage II | Breast Cancer Female | Breast Cancer Stage III | Estrogen Receptor-positive Breast Cancer | Hormone Receptor-positive Breast Cancer | Breast Cancer InvasiveUnited States
-
UNC Lineberger Comprehensive Cancer CenterCompletedBreast Cancer | Breast Cancer FemaleUnited States
-
University of RochesterRecruitingBreast Cancer Female | Cancer Related Cognitive DifficultiesUnited States
-
Adrienne G. WaksGilead SciencesRecruitingBreast Cancer Female | Breast Cancer Metastatic | Her 2 Positive Breast CancerUnited States
-
Leap Therapeutics, Inc.Pfizer; Merck KGaA, Darmstadt, GermanyTerminatedSolid Tumors | Advanced Triple Negative Breast Cancer | Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer | Advanced Metastatic Castration-Resistant Prostate Cancer | Advanced Platinum-Resistant Ovarian CancerUnited States
-
Filipa Lynce, MDMerck Sharp & Dohme LLC; Zentalis PharmaceuticalsNot yet recruitingBreast Cancer | Triple Negative Breast Cancer | Breast Cancer Female | HER2-negative Breast Cancer | Hormone Receptor Negative Malignant Tumor Breast TripleUnited States
-
University of Texas Southwestern Medical CenterCancer Prevention Research Institute of TexasActive, not recruitingBreast Cancer FemaleUnited States
-
University of Colorado, DenverEnrolling by invitationSexual Dysfunction | Breast Cancer FemaleUnited States
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedPhysical Activity | Breast Cancer FemaleUnited States
-
MGH Institute of Health ProfessionsNational Cancer Institute (NCI)Active, not recruiting
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast Cancer | Hereditary Breast/Ovarian Cancer - BRCA1 | Hereditary Breast/Ovarian Cancer...United States